New drug aims to save sight in optic neuritis patients
NCT ID NCT07623668
First seen Jun 04, 2026 · Last updated Jun 11, 2026 · Updated 2 times
Summary
This study tests a new drug called privosegtor in 210 adults with a first episode of optic neuritis, a condition that causes sudden vision loss. Participants receive either privosegtor or a placebo, both alongside standard steroid treatment. The goal is to see if the drug helps recover vision and protects the optic nerve from damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPTIC NEURITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neuro-Eye Clinical Trials
RECRUITINGHouston, Texas, 77074, United States
Conditions
Explore the condition pages connected to this study.